These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 11130452
1. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome. Yuki N. Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452 [Abstract] [Full Text] [Related]
2. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Yuki N. Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987 [Abstract] [Full Text] [Related]
5. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. Prendergast MM, Moran AP. J Endotoxin Res; 2000 Jun; 6(5):341-59. PubMed ID: 11521055 [Abstract] [Full Text] [Related]
8. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Neurology; 2005 Nov 08; 65(9):1376-81. PubMed ID: 16162859 [Abstract] [Full Text] [Related]
9. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Yuki N. Lancet Infect Dis; 2001 Aug 08; 1(1):29-37. PubMed ID: 11871407 [Abstract] [Full Text] [Related]
11. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Ang CW, De Klerk MA, Endtz HP, Jacobs BC, Laman JD, van der Meché FG, van Doorn PA. Infect Immun; 2001 Apr 08; 69(4):2462-9. PubMed ID: 11254608 [Abstract] [Full Text] [Related]
12. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection. Yuki N, Miyatake T. Ann N Y Acad Sci; 1998 Jun 19; 845():330-40. PubMed ID: 9668366 [Abstract] [Full Text] [Related]
14. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome. Jacobs BC, Endtz HP, van der Meché FG, Hazenberg MP, de Klerk MA, van Doorn PA. J Neuroimmunol; 1997 Oct 19; 79(1):62-8. PubMed ID: 9357448 [Abstract] [Full Text] [Related]
15. Anti-ganglioside antibody and neuropathy: review of our research. Yuki N. J Peripher Nerv Syst; 1998 Oct 19; 3(1):3-18. PubMed ID: 10959233 [Abstract] [Full Text] [Related]
17. Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barré Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain. Zhang M, Gilbert M, Yuki N, Cao F, Li J, Liu H, Li Q, Meng F, Zhang J. PLoS One; 2015 Oct 19; 10(7):e0131730. PubMed ID: 26197476 [Abstract] [Full Text] [Related]
18. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes. Houliston RS, Yuki N, Hirama T, Khieu NH, Brisson JR, Gilbert M, Jarrell HC. Biochemistry; 2007 Jan 09; 46(1):36-44. PubMed ID: 17198373 [Abstract] [Full Text] [Related]
19. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections. Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H, Saida K. J Neuroimmunol; 1998 Jan 09; 81(1-2):116-26. PubMed ID: 9521613 [Abstract] [Full Text] [Related]
20. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M. Proc Natl Acad Sci U S A; 2004 Aug 03; 101(31):11404-9. PubMed ID: 15277677 [Abstract] [Full Text] [Related] Page: [Next] [New Search]